Vascular Surgery - Guideline for Antimicrobial Prophylaxis

Publication: 14/08/2009  
Next review: 15/09/2025  
Clinical Guideline
CURRENT 
ID: 1677 
Approved By: Improving Antimicrobial Prescribing Group 
Copyright© Leeds Teaching Hospitals NHS Trust 2022  

 

This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated.
For healthcare professionals in other trusts, please ensure that you consult relevant local and national guidance.

GUIDELINE FOR ANTIMICROBIAL PROPHYLAXIS FOR VASCULAR SURGERY

RECOMMENDED ROUTINE PROPHYLAXIS OPTIONS

General comments:

  1. Where the recommended antibiotic choice in these guidelines does not seem appropriate for a particular patient, for example due to known infection/ colonisation with drug resistant bacteria, the surgeon is advised to discuss antibiotic prophylaxis choice with the Duty Microbiology team pre-operatively.
  2. Patients already on antibiotic TREATMENT
    for infection related to the site of surgery do NOT require additional prophylaxis. If a regular prescribed dose of antibiotic treatment coincides with the timing of the operation ensure that it is administered intra-operatively and not omitted.
  3. Antimicrobial dose/route
    Give within 30mins (or up to maximum 1 hour) prior to incision (additional doses may be required1)
  4. Further intra-operative doses
    are required of some antibiotics for prolonged procedures or if the patient undergoes total body volume transfusion. For example:
    • Flucloxacillin electronic Medicines Compendium information on Flucloxacillin after 4 hours of surgery
    • Metronidazole electronic Medicines Compendium information on Metronidazole after 8 hours of surgery.
    • Do NOT give another dose Teicoplanin electronic Medicines Compendium information on Teicoplanin or Vancomycin electronic Medicines Compendium information on Vancomycin.
    • Gentamicin dose can be repeated after 8 hours if patient undergoes total volume transfusion, ensure total daily dose does not exceed 7mg/kg based on ideal body weight.

Procedure

Routine

MRSA Risk2

Penicillin allergy

Arterial surgery including:

Aortic surgery
(all approaches including EVAR);

Peripheral arterial surgery (except carotid)

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV2g
AND
Gentamicin IV 2mg/kg1 single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV400mg AND
Gentamicin IV 2mg/kg1  single dose3

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV400mg
AND
Gentamicin IV 2mg/kg1 single dose3

Post op doses:

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV 1gat 6, 12 & 18 hours

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mgat 12 hours

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mgat 12 hours

Carotid surgery

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV2g single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg  single dose

Amputations

(patient NOT already on treatment for infection at site of planned surgery)

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV 2g
AND
Gentamicin IV 2mg/kg1
AND
Metronidazoleelectronic Medicines Compendium information on Metronidazole IV 500mg

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg
AND
Gentamicin IV3 2mg/kg1
AND
Metronidazoleelectronic Medicines Compendium information on MetronidazoleIV 500mg

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg
AND
Gentamicin IV3 2mg/kg1
AND
Metronidazoleelectronic Medicines Compendium information on MetronidazoleIV 500mg

Post op doses first 24hrs:

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV1gat 6, 12 & 18 hrs
AND
Metronidazoleelectronic Medicines Compendium information on Metronidazole IV 500mg at 8 and 16 hrs

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV400mg at 12 hrs
AND
Metronidazoleelectronic Medicines Compendium information on MetronidazoleIV 500mg at 8 and 16 hrs

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg at 12 hrs
AND
Metronidazoleelectronic Medicines Compendium information on MetronidazoleIV 500mg at 8 and 16 hrs

Further post-op doses see note 4 below

Open Varicose Vein surgery: Recommended only if ulcerated or high risk e.g. morbidly obese

Flucloxacillinelectronic Medicines Compendium information on FlucloxacillinIV 2g single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Varicose veins: Sclerotherapy or
endovenous laser ablation

Prophylaxis not recommended

A-V fistula formation: Basilic vein transposition and synthetic grafts only

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

A-V fistula formation: Radiocephalic or brachiocephalic fistula formation

Prophylaxis not recommended

Peritoneal dialysis catheter insertion

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Teicoplaninelectronic Medicines Compendium information on TeicoplaninIV 400mg single dose

Angiogram or angioplasty

Prophylaxis not recommended

Haemodialysis Line Insertion

Prophylaxis not recommended

FOOTNOTES

  1. Gentamicin dosing should be based on ideal body weight (IBW). Use actual body weight if less than ideal body weight.  https://www.mdcalc.com/calc/68/ideal-body-weight-adjusted-body-weight.
  2. MRSA Risk factors
    Patients within these categories are considered at increased risk of MRSA infection:
    1. Known previous infection or colonisation with MRSA at any time.
    2. Resident of a long term care facility (nursing home, residential home or any other long term residential facility) without a negative MRSA screening result.
    3. Any history of inpatient hospital stay within the previous 6 months without a negative MRSA screening result
  3. Teicoplanin and Gentamicin are incompatible; ALWAYS flush between administrations.
  4. Trans-Metatarsal Amputations (TMAs) and more proximal amputations ONLY:
    Post-operative antibiotic prophylaxis may be extended from 24hrs to maximum 5 days post-operatively at the discretion of the responsible vascular consultant.

    Regimen: Doxycycline 100mg BD PO + Metronidazole 400mg TDS PO for maximum 4 days.

    This is based on a single centre, single blinded randomised trial of 5 days of post-op prophylactic antibiotics for TMA or more proximal amputations demonstrating a significant reduction in surgical site infection and impaired wound healing when compared with 24hrs prophylaxis. There was no impact on length of stay or mortality, and limited data on side effects.

Provenance

Record: 1677
Objective:
Clinical condition:

Peripheral arterial disease

Target patient group: Vascular
Target professional group(s): Pharmacists
Secondary Care Doctors
Secondary Care Nurses
Adapted from:

Evidence base

  • NICE guidelines [NG125] 2019 Surgical Site Infections: prevention and treatment of surgical site infection
  • Global guidelines for the prevention of Surgical Site Infections, second edition. Geneva, World Health Organisation, 2018. Licence: CC BY-NC-SA 3.0 IGO.
  • Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial. Souroullas P et al. British Journal of Surgery, 2022, 109, 426-432

Approved By

Improving Antimicrobial Prescribing Group

Document history

LHP version 2.0

Related information

Not supplied

Equity and Diversity

The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.